ArticleJournal of Cancer2022

Hinokitiol impedes tumor drug resistance by suppressing protein kinase B/mammalian targets of rapamycin axis.

Ying-Jui Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.